刚刚!​中国首款肺癌EGFR 20ins靶向药莫博赛替尼TAK788震撼上市!

2023-01-131614

刚刚!​中国首款肺癌EGFR 20ins靶向药莫博赛替尼TAK788震撼上市!

2023-01-131614

视频内容

相关视频